Novir is a cutting-edge biotechnology company revolutionizing the way the world perceives and approaches healthcare. At Novir, we challenge the conventional care model by placing our focus on proactive measures rather than waiting for diagnoses. We firmly believe that care shouldn't start at diagnosis, but rather in the early stages of prevention. Our mission is to empower individuals to take charge of their health through innovative services and technologies that enable a pre-care pathway for anyone, anywhere, anytime.
| Website | http://novir-usa.com |
| Revenue | $190.6 million |
| Employees | 46 (38 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
PHP
+24 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Cutting Edge Technology, Healthcare, Proactive Healthcare, Medical Innovation, Preventative Medicine, Health Innovation, Precision Medicine, Biomedical Research, Therapeutic Solutions, Personalized Medicine, Pharmaceutical Research, Drug Discovery, Health Technology, Therapeutics, Medical Technology, Clinical Research, Health Solutions, Wellness |
| Competitors | Mayo Clinic Laboratories, Roche, Thermo Fisher Scientific, GE HealthCare, PerkinElmer, Inc., Labcorp, Abbott, Quest Diagnostics, Ambry Genetics, Sonic Healthcare +35 more (view full list) |
Looking for a particular Novir employee's phone or email?
The Novir annual revenue was $190.6 million in 2026.
Alexander Kempe Cañal y de Orozco is the CEO and Founder of Novir.
38 people are employed at Novir.